These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 36035063)

  • 21. Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia.
    Donepudi B; Agarwal S; Thakur L
    Case Rep Crit Care; 2022; 2022():8807957. PubMed ID: 36267193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic sinus bradycardia due to electrolyte imbalances in syndrome of inappropriate antidiuretic hormone (SIADH) related covid-19: a case report.
    Amir M; Renata A; Ratana LT
    BMC Infect Dis; 2021 May; 21(1):465. PubMed ID: 34020617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.
    Anderson J; Schauer J; Bryant S; Graves CR
    Case Rep Womens Health; 2020 Jul; 27():e00221. PubMed ID: 32426243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.
    Kundu A; Fitzgibbons TP
    J Med Case Rep; 2015 Sep; 9():216. PubMed ID: 26400725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review.
    Roshanshad A; Kamalipour A; Ashraf MA; Roshanshad R; Jafari S; Nazemi P; Akbari M
    Iran J Microbiol; 2020 Oct; 12(5):376-387. PubMed ID: 33603991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bradycardia in Patients With COVID-19: A Calm Before the Storm?
    Amaratunga EA; Corwin DS; Moran L; Snyder R
    Cureus; 2020 Jun; 12(6):e8599. PubMed ID: 32550090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
    Sun D
    AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Multicenter Retrospective Analysis on the Etiology of Bradycardia in COVID-19 Patients.
    Umeh C; Giberson C; Kumar S; Aseri M; Barve P
    Cureus; 2022 Jan; 14(1):e21294. PubMed ID: 35186556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential.
    Deb S; Reeves AA; Hopefl R; Bejusca R
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient.
    Harbi SA; AlFaifi M; Al-Dorzi HM; Aljuhani O; Alenazi AA; Alalawi M; Sulaiman KA
    IDCases; 2022; 29():e01572. PubMed ID: 35855472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Montastruc F; Thuriot S; Durrieu G
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
    Davies M; Osborne V; Lane S; Roy D; Dhanda S; Evans A; Shakir S
    Drug Saf; 2020 Jul; 43(7):645-656. PubMed ID: 32468196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease.
    Jacinto JP; Patel M; Goh J; Yamamura K
    HeartRhythm Case Rep; 2021 Aug; 7(8):514-517. PubMed ID: 34026493
    [No Abstract]   [Full Text] [Related]  

  • 34. Early experience with remdesivir in SARS-CoV-2 pneumonia.
    Durante-Mangoni E; Andini R; Bertolino L; Mele F; Florio LL; Murino P; Corcione A; Zampino R
    Infection; 2020 Oct; 48(5):779-782. PubMed ID: 32418190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report.
    Saroyo YB; Rumondang A; Febriana IS; Harzif AK; Irwinda R
    Infect Dis Rep; 2021 May; 13(2):437-443. PubMed ID: 34067822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of remdesivir in SARS-CoV-2: A single tertiary care center experience from a developing country.
    Malik MI; Zafar SAF; Malik M; Qayyum F; Akram I; Arshad A; Waheed K; Saleem J; Jabbar A; Tahir MJ; Yousaf Z
    Explor Res Clin Soc Pharm; 2022 Mar; 5():100107. PubMed ID: 35156078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.
    Lim S; DeBruin DA; Leider JP; Sederstrom N; Lynfield R; Baker JV; Kline S; Kesler S; Rizza S; Wu J; Sharp RR; Wolf SM
    Mayo Clin Proc; 2020 Sep; 95(9):1946-1954. PubMed ID: 32861338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Liver Failure Secondary to Remdesivir in the Treatment of COVID-19.
    Lin K; Gausman V; Poles M; Popov V
    ACG Case Rep J; 2022 Oct; 9(10):e00866. PubMed ID: 36212242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Symptomatic Sinus Bradycardia in High-Dose Methylprednisolone Therapy in a Woman With Inflammatory Myelitis: A Case Report and Review of the Literature.
    Sodero A; Squitieri M; Mazzeo S; Pasca M; Matà S; Pieri F; Bessi V; Sorbi S
    Clin Med Insights Case Rep; 2019; 12():1179547619831026. PubMed ID: 30828250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remdesivir induced bradycardia and QT prolongation: A rare side effect of a ubiquitous drug of the COVID -19 era.
    Singla K; Kumar S; Behl A; Puri GD
    J Anaesthesiol Clin Pharmacol; 2022 Jul; 38(Suppl 1):S148-S149. PubMed ID: 36060176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.